| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Valeant Pharmaceuticals Intl Inc
| TSE
|
VRX
|
84.64
|
|
+7.80
(10.15%)
| 25.72B
|
|
|
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a
multinational, specialty pharmaceutical company that develops, ...
| |
| |
|
|
Valeant Pharmaceuticals Intl Inc
| NYSE
|
VRX
|
83.02
|
|
+8.35
(11.18%)
| 25.22B
|
|
|
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a
multinational, specialty pharmaceutical company that develops, ...
| |
| |
|
|
VRX Worldwide Inc.
| CVE
|
VRW
|
0.030
|
|
0.000
(0.00%)
| 1.04M
|
|
|
The Company, through its wholly owned subsidiary, VRX Studios Inc. (VRX), is a
provider of content production, management and licensing services.
| |
| |
|
|
Ventnor Resources Ltd
| ASX
|
VRX
|
0.370
|
|
0.000
(0.00%)
| 22.38M
|
|
|
Ventnor Resources Limited (Ventnor) is a base metals explorer. The Company
focuses on the discovery and development of economic mineral deposits.
| |
| |
|
|
VRX WORLDWIDE INC
| OTCMKTS
|
VRXWF
|
|
|
|
|
|
|
|
|
